Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Regulatory News (ARIX)

  • There is currently no data for ARIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Mar 2018 11:39

RNS Number : 4572I
Arix Bioscience Plc
21 March 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Arix Bioscience plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Fosun International Holdings Ltd.

City and country of registered office (if applicable)

Tortola, VG1110, British Virgin Islands

Name

Mr. Guo Guangchang

City and country of registered office (if applicable)

Hong Kong

4. Full name of shareholder(s) (if different from 3.)v

Name

Fosun Industrial Holdings Limited

City and country of registered office (if applicable)

Fosun Industrial Holdings Limited, Room 808, ICBC Tower, 3 Garden Road, Central, Hong Kong

5. Date on which the threshold was crossed or reachedvi:

20/03/2018

6. Date on which issuer notified (DD/MM/YYYY):

21/03/2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Mr. Guo Guangchang

Resulting situation on the date on which threshold was crossed or reached

8.24% (indirectly)

8.24%

11,111,111

Position of previous notification (if

applicable)

N/A

N/A

N/A

Fosun International Holdings Ltd.

Resulting situation on the date on which threshold was crossed or reached

8.24% (indirectly)

8.24%

11,111,111

Position of previous notification (if

applicable)

N/A

N/A

N/A

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Mr. Guo Guangchang

Class/type ofshares

ISIN code (if possible)

 

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary shares ISIN: GB00BD045071

0

11,111,111

0%

8.24%

SUBTOTAL 8. A

11,111,111

8.24%

Fosun International Holdings Ltd.

Class/type ofshares

ISIN code (if possible)

 

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary shares ISIN: GB00BD045071

0

11,111,111

0%

8.24%

SUBTOTAL 8. A

11,111,111

8.24%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

x

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Mr. Guo Guangchang

8.24% indirectly

0%

8.24% indirectly

Fosun International Holdings Ltd.

8.24% indirectly

0%

8.24% indirectly

Fosun Holdings Limited

8.24% indirectly

0%

8.24% indirectly

Fosun International Limited

8.24% indirectly

0%

8.24% indirectly

Fosun Industrial Holdings Limited

8.24% directly

0%

8.24% directly

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Mr. Guo Guangchang and Fosun International Holdings Ltd. are each making disclosures in accordance with DTR 5.1.2 as a result of their indirect shareholding in the issuer (pursuant to DTR 5.2.1R(e)) as a result of the direct shareholding of Fosun Industrial Holdings Limited.

Mr. Guo Guangchang and Fosun International Holdings Ltd. are making a single common notification pursuant to DTR 5.8.4R.

Fosun International Holdings Ltd. is making the notification as a parent undertaking on behalf of its subsidiaries, pursuant to DTR 5.8.6R.

 

Place of completion

London, UK

Date of completion

20 March 2018

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLJBMBTMBJTBAP
Date   Source Headline
1st Oct 20217:00 amEQSTotal Voting Rights
30th Sep 20215:30 pmEQSTransaction in own shares
29th Sep 20215:30 pmEQSTransaction in own shares
28th Sep 20215:30 pmEQSTransaction in own shares
28th Sep 20218:16 amEQSArtios Doses First Patient in Phase 1/2a Study of Polθ Inhibitor ART4215
27th Sep 20215:30 pmEQSTransaction in own shares
24th Sep 20215:30 pmEQSTransaction in own shares
23rd Sep 20215:30 pmEQSTransaction in own shares
22nd Sep 20215:30 pmEQSTransaction in own shares
21st Sep 20216:00 pmEQSTransaction in own shares
20th Sep 20215:30 pmEQSTransaction in own shares
17th Sep 20215:30 pmEQSTransaction in own shares
16th Sep 20216:00 pmEQSTransaction in own shares
15th Sep 20215:30 pmEQSTransaction in own shares
14th Sep 20215:30 pmRNSTransaction in own shares
13th Sep 20215:30 pmEQSTransaction in own shares
10th Sep 20215:30 pmEQSTransaction in own shares
9th Sep 20215:30 pmEQSTransaction in own shares
8th Sep 20215:30 pmEQSTransaction in own shares
7th Sep 20215:30 pmEQSTransaction in own shares
3rd Sep 20215:30 pmEQSTransaction in own shares
2nd Sep 20215:30 pmEQSTransaction in own shares
2nd Sep 202111:21 amEQSArix Bioscience participates in $90 million Series B financing for Disc Medicine
1st Sep 20215:30 pmEQSTransaction in own shares
1st Sep 20217:00 amEQSTotal Voting Rights
31st Aug 20215:30 pmEQSTransaction in own shares
27th Aug 20215:30 pmEQSTransaction in own shares
26th Aug 20215:30 pmEQSTransaction in own shares
25th Aug 20215:30 pmEQSTransaction in own shares
24th Aug 20215:30 pmEQSTransaction in own shares
23rd Aug 20215:30 pmEQSTransaction in own shares
20th Aug 20215:30 pmEQSTransaction in own shares
19th Aug 20215:15 pmEQSTransaction in own shares
18th Aug 20215:30 pmEQSTransaction in own shares
17th Aug 20215:45 pmEQSTransaction in own shares
16th Aug 20215:30 pmEQSTransaction in own shares
16th Aug 20217:00 amEQSDirector/PDMR Shareholding
13th Aug 20215:30 pmEQSTransaction in own shares
12th Aug 20215:30 pmEQSTransaction in own shares
12th Aug 20217:01 amEQSInterim Results for the Six Months Ended 30 June 2021
11th Aug 20215:30 pmEQSTransaction in own shares
10th Aug 20215:30 pmEQSTransaction in own shares
9th Aug 20215:30 pmEQSTransaction in own shares
6th Aug 20215:30 pmEQSTransaction in own shares
5th Aug 20215:15 pmEQSTransaction in own shares
4th Aug 20215:28 pmEQSTransaction in own shares
3rd Aug 20215:20 pmEQSTransaction in own shares
2nd Aug 20215:25 pmEQSTransaction in own shares
2nd Aug 20217:00 amEQSTotal Voting Rights
30th Jul 20215:15 pmEQSTransaction in own shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.